Drugs / Huangjing Yangji Formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07321535 | Jan → Sep 2026 overdue | muscular atrophy | Wangjing Hospital, China Academy of Chinese Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huangjing Yangji Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07321535 ↗ |
| Known as | Huangjing Yangji Formula Granules | “This preparation is specifically designed to be indistinguishable from the active "Huangjing Yangji Formula Granules" in terms of appearance, color, odor, packaging, and solubility.” NCT07321535 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine formula called "Huangjing Yangji Formula"” NCT07321535 ↗ |
| Route | Oral | “Administered orally as granules dissolved in water” NCT07321535 ↗ |